Shared insight on the importance of patient adherence in glaucoma management, and how this is influenced by therapeutic regimens. Neil Minkoff, MD: What are the things that you folks see in your ...

Glaukos has concluded patient enrolment in its US 510(k) pivotal trial assessing the Preserflo MicroShunt drainage device in adults with primary open-angle glaucoma. The study tar ...

Patients in rural communities were also more likely than patients in urban areas to experience loss to follow-up. These findings underscore the association between patient wealth and glaucoma care and ...

Communicating to patients that they need to come to their annual checkup is important for eye doctors to convey to help treat their patients, says Ariana Levin, MD. Glaucoma is a disease that affects ...

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal ...

Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today ...

Markers in the blood that predict whether glaucoma patients are at higher risk of continued loss of vision following conventional treatment have been identified by researchers. Markers in the blood ...

Please provide your email address to receive an email when new articles are posted on . I was honored to give the Stephen A. Obstbaum, MD, Lecture at the 2022 American Society of Cataract and ...

Patients with endogenous Cushing syndrome (CS) have a higher risk for glaucoma than the general population, with the clinical manifestations appearing at a younger age. The risk persisted regardless ...

How equitably are glaucoma medications being dispensed across a universal health care system, and how have prescribing ...